National
Oxford coronavirus vaccine: Five things to know – Al Jazeera English
Early trial results of vaccine developed in the UK show it induced ‘robust immune responses’.

Promising results from trials of three potential coronavirus vaccines have raised hopes in the fight against the COVID-19 pandemic, which has killed more than 600,000 people and crushed economies globally.
Early-stage clinical trials of AZD1222, a closely-watched experimental vaccine being developed by AstraZeneca and scientists at Oxford University in the United Kingdom, induced “robust immune responses” in participants without any serious side-effects, according to results published in The La…

Continue Reading